BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37770363)

  • 1. Perioperative disabilities in activities of daily living are associated with worse prognosis after hepatectomy for colorectal liver metastasis.
    Mima K; Hayashi H; Maruno M; Yumoto S; Matsumoto T; Tsukamoto M; Miyata T; Nakagawa S; Nitta H; Imai K; Baba H
    HPB (Oxford); 2024 Feb; 26(2):203-211. PubMed ID: 37770363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient vulnerability is associated with poor prognosis following upfront hepatectomy for colorectal liver metastasis.
    Mima K; Hayashi H; Adachi Y; Tajiri T; Ofuchi T; Kanemitsu K; Ogawa D; Yumoto S; Matsumoto T; Itoyama R; Kitano Y; Nakagawa S; Okabe H; Baba H
    Int J Clin Oncol; 2024 Jan; 29(1):47-54. PubMed ID: 37943377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of perioperative activities of daily living is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.
    Mima K; Imai K; Kaida T; Matsumoto T; Nakagawa S; Sawayama H; Hayashi H; Yamashita YI; Baba H
    J Surg Oncol; 2022 Nov; 126(6):995-1002. PubMed ID: 35796726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability in perioperative activities of daily living is associated with worse survival outcomes following hepatic resection in patients with intrahepatic cholangiocarcinoma.
    Mima K; Hayashi H; Yumoto S; Matsumoto T; Tsukamoto M; Miyata T; Nakagawa S; Nitta H; Baba H
    Hepatol Res; 2023 Feb; 53(2):135-144. PubMed ID: 36305859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 6. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy.
    Takematsu T; Mima K; Hayashi H; Kitano Y; Nakagawa S; Hiyoshi Y; Okabe H; Imai K; Miyamoto Y; Baba H
    J Hepatobiliary Pancreat Sci; 2024 Feb; 31(2):69-79. PubMed ID: 37897144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative infectious complications are associated with diminished overall survival of patients undergoing resection for colorectal liver metastases.
    Knitter S; Noltsch AR; Pesthy S; Beierle AS; Krenzien F; Schöning W; Andreou A; Pratschke J; Schmelzle M
    Eur J Surg Oncol; 2023 Sep; 49(9):106920. PubMed ID: 37121813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
    Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
    Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
    Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
    Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of Activities of Daily Living is an Independent Risk Factor for Recurrence and Mortality Following Curative Resection of Stage I-III Colorectal Cancer.
    Mima K; Kosumi K; Miyanari N; Tajiri T; Kanemitsu K; Takematsu T; Inoue M; Mizumoto T; Kubota T; Baba H
    J Gastrointest Surg; 2021 Oct; 25(10):2628-2636. PubMed ID: 33825120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
    Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
    Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases.
    Sutton TL; Wong LH; Walker BS; Dewey EN; Eil RL; Ibewuike U; Chen EY; Rocha FG; Billingsley KG; Mayo SC
    J Surg Oncol; 2022 Jun; 125(8):1260-1268. PubMed ID: 35212404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative impact of fresh-frozen plasma transfusion on prognosis after hepatic resection for liver metastases from colorectal cancer.
    Shiba H; Ishida Y; Haruki K; Furukawa K; Fujiwara Y; Iwase R; Ohkuma M; Ogawa M; Misawa T; Yanaga K
    Anticancer Res; 2013 Jun; 33(6):2723-8. PubMed ID: 23749932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis.
    Ueno H; Konishi T; Ishikawa Y; Shimazaki H; Ueno M; Aosasa S; Saiura A; Hase K; Yamamoto J
    Surgery; 2015 May; 157(5):899-908. PubMed ID: 25731780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy.
    Hori Y; Seo S; Yoh T; Ueno K; Morino K; Toda R; Nishio T; Koyama Y; Fukumitsu K; Ishii T; Hata K; Masui T; Taura K; Hatano E
    Ann Surg Oncol; 2022 Oct; 29(11):6745-6754. PubMed ID: 35691953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.
    Tufo A; Dunne DFJ; Manu N; Joshi H; Lacasia C; Jones L; Malik HZ; Poston GJ; Fenwick SW
    Eur J Surg Oncol; 2018 Jul; 44(7):1040-1047. PubMed ID: 29456045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.